Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Sales | 69 | 80 | 1,140 | 1,560 | 2,170 |
| Gross Profit | 69 | 80 | 1,140 | 1,560 | 2,170 |
| Operating Expenses | 5,413 | 6,180 | 3,180 | 11,540 | 13,890 |
| Operating Income | -5,344 | -6,100 | -2,040 | -9,980 | -11,720 |
| Interest Expense | 53 | 650 | 130 | 0 | 10 |
| Other Income | -232 | -200 | 630 | 960 | -10 |
| Pre-tax Income | -5,629 | -6,950 | -1,540 | -9,020 | -11,740 |
| Income Tax | N/A | 0 | 0 | 0 | 1 |
| Net Income Continuous | -5,629 | -7,427 | -1,802 | -6,282 | -7,881 |
| Net Income Discontinuous | N/A | 0 | 740 | 7,630 | 0 |
| Minority Interests | -129 | N/A | N/A | N/A | N/A |
| Net Income | $-5,500 | $-6,950 | $-800 | $-1,390 | $-11,740 |
| EPS Basic Total Ops | -115.00 | -236.00 | -46.00 | 68.00 | -320.00 |
| EPS Basic Continuous Ops | -117.70 | -237.28 | -78.69 | -312.54 | -388.23 |
| EPS Basic Discontinuous Ops | N/A | N/A | 32.31 | 379.60 | N/A |
| EPS Diluted Total Ops | -115.00 | -236.00 | -46.00 | 68.00 | -320.00 |
| EPS Diluted Continuous Ops | -117.70 | -237.28 | -78.69 | -312.54 | -388.23 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 32.31 | 379.60 | N/A |
| EBITDA(a) | $-4,901 | $-5,580 | $-1,700 | $-9,960 | $-11,640 |